Escape to the future: Pharmaceutical industry wants to improve access to medicines

The EU Commission intends to revise European pharmaceutical legislation at the end of 2022. Even during the consultations at the end of 2021, the pharmaceutical industry did not see any fundamental need for improvement. However, now, it is taking the plunge and presenting its own proposals to make access to medicines faster and fairer for millions of patients in the EU.